Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate to prevent periprosthetic bone loss after hip arthroplasty
2004-002965-19Phase 4Active
- Sponsor
- Orthopaedic department, Karolinska Institutet, Danderyd's Hospital
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of risedronate in hip osteoarthritis and Aseptic loosening (AL), sponsored by Orthopaedic department, Karolinska Institutet, Danderyd's Hospital. Primary endpoint: Periprosthetic bone remodeling. Started Feb 2005; status: active.
02
Drugs
risedronate
03
Conditions
hip osteoarthritisAseptic loosening (AL)
Beyond the preview
Go deeper on 2004-002965-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002965-19.